Publications by authors named "Ann Ranger"

Claim this Profile
R
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20 B Cell Lymphoma.
Javier Munoz, Ian W Flinn, Jonathon B Cohen, Jessica Sachs, Benjamin Exter, Ann Ranger

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus.
Michelle Petri, Wei Fu, Ann Ranger, Norm Allaire, Patrick Cullen

BMC Med Genomics· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies.
Ann Ranger, Soma Ray, Suzanne Szak, Andrea Dearth, Norm Allaire

Neurol Neuroimmunol Neuroinflamm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles.
Chris Chamberlain, Peter J Colman, Ann M Ranger, Linda C Burkly, Geoffrey I Johnston

Ann Rheum Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in urinary collagen peptides in lupus nephritis subjects correlate with renal dysfunction and renal histopathology.
Ru Wei, Benbo Gao, Fei Shih, Ann Ranger, Andrea Dearth

Nephrol Dial Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
Agnes Gardet, Wei C Chou, Taylor L Reynolds, Diana B Velez, Kai Fu, Ann M Ranger

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Application of a Modular Genomics Technique in Systemic Lupus Erythematosus: Progress towards Precision Medicine.
Eric Zollars, Sean M Courtney, Bethany J Wolf, Norm Allaire, Ann Ranger

Int J Genomics· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lymphotoxin β receptor is a potential therapeutic target in renal inflammation.
Gitta Seleznik, Harald Seeger, Judith Bauer, Kai Fu, Julie Czerkowicz, Ann Ranger

Kidney Int· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year.
Eric Zollars, Jadwiga Bienkowska, Julie Czerkowicz, Norm Allaire, Ann M Ranger

Lupus Sci Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis.
Keith R Edwards, Jaya Goyal, Tatiana Plavina, Julie Czerkowicz, Susan Goelz, Ann Ranger

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing.
Dharma R Thapa, Raffi Tonikian, Chao Sun, Mei Liu, Andrea Dearth, Ann Ranger

Arthritis Res Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms.
Alex Pellerin, Karel Otero, Julie M Czerkowicz, Hannah M Kerns, Renée I Shapiro, Ann M Ranger

EMBO Mol Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Mathangi Srinivasan, Ryan Flynn, Andrew Price, Ann Ranger, Jeffrey L Browning

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.
Douglas D McCarthy, Julie Kujawa, Cheryl Wilson, Adrian Papandile, Urjana Poreci, Ann Ranger

J Clin Invest· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAD is a pro-survival factor prior to activation of its pro-apoptotic function.
So Young Seo, Ying-Bei Chen, Iva Ivanovska, Ann M Ranger, Suk J Hong

J Biol Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bad-deficient mice develop diffuse large B cell lymphoma.
Ann M Ranger, Jiping Zha, Hisashi Harada, Sandeep Robert Datta, Nika N Danial

Proc Natl Acad Sci U S A· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis.
Nika N Danial, Colette F Gramm, Luca Scorrano, Chen-Yu Zhang, Stefan Krauss, Ann M Ranger

Nature· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis.
Sandeep Robert Datta, Ann M Ranger, Michael Z Lin, James Fitzhugh Sturgill, Yong-Chao Ma

Dev Cell· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor.
Andrew P Gilmore, Anthony J Valentijn, Pengbo Wang, Ann M Ranger, Nigel Bundred

J Biol Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis